David JIANG, MD, PhD
- Jiahui International Cancer Center
- Medical Oncology
- Jiahui International Hospital (Shanghai)
- Languages:普通话, English
Dr. David JIANG，Medical Doctor, associate chief physician, associate professor, is currently an attending physician and the deputy chief of Medical Oncology in Jiahui International Cancer Center. Dr. Jiang graduated from Fudan Universty. Before joining Jiahui Health, Dr. Jiang has worked more than a decade in Huashan Hospital, Fudan University.
Dr. Jiang was occupied mainly with the chemotherapy, targeted therapy, immunotherapy and vascular interventional treatment of malignant solid tumor, and accumulated rich experience in comprehensive therapy of solid tumor, such as colorectal cancer, gastric cancer, primary and secondary liver cancer, pancreatic cancer, gallbladder cancer, esophageal cancer, lung cancer, tumors of the genitourinary system and head and neck. He has also accumulated some experience on rare malignant tumor. He is also good at the procedure of totally implantable venous access port systems (port). Dr. Jiang has obtained certification of three to four-level comprehensive interventional diagnosis and treatment techniques for malignant tumor from Shanghai Medical Association. Dr. Jiang devotes himself to Evidence-based Medicine, and individualized precise diagnosis and treatment concept. He also always pays attention to humanistic care for patients with tumor.
He has presided over and taken part in several national natural science foundation of China (NSFC). He was also supported by the fund of the first session training program for young doctors of Shanghai City and HuaJing award of Huashan hospital, Fudan University, which encourages excellent attending physician. As the first author, he has published more than 10 peer-reviewed papers in SCI Journals such as Journal of Thoracic Oncology, Lung Cancer and Cancer Medicine. Three of these papers were cited by four Clinical Practice Guidelines or Expert Consensus published by American Society of Clinical Oncology (ASCO), European Society for Medical Oncology (ESMO) and American College of Chest Physicians (ACCP).
Dr. Jiang is a committee member of Precision Medicine Expert Committee of Shanghai Biomedical Industry Association, and a committee member of the first session of Vascular Access Expert Committee of Solid Tumor Focus Diagnosis and Treatment Specialized Committee of Shanghai Anticancer Association. He is also a current member of ASCO，CSCO and Chinese Medical Association.